BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17234736)

  • 1. The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia.
    Agrawal S; Hofmann WK; Tidow N; Ehrich M; van den Boom D; Koschmieder S; Berdel WE; Serve H; Müller-Tidow C
    Blood; 2007 May; 109(9):3895-905. PubMed ID: 17234736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis of the effects and mechanisms of decitabine and cytarabine on acute myeloid leukemia.
    Zhou S; Liu P; Zhang H
    Mol Med Rep; 2017 Jul; 16(1):281-287. PubMed ID: 28498449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of CCAAT/Enhancer Binding proteindelta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells.
    Zhang Y; Liu T; Yan P; Huang T; Dewille J
    BMC Mol Biol; 2008 Oct; 9():83. PubMed ID: 18828910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-aza-2'-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells.
    Tsujioka T; Yokoi A; Itano Y; Takahashi K; Ouchida M; Okamoto S; Kondo T; Suemori S; Tohyama Y; Tohyama K
    Sci Rep; 2015 Nov; 5():16709. PubMed ID: 26577244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia.
    Aucagne R; Droin N; Paggetti J; Lagrange B; Largeot A; Hammann A; Bataille A; Martin L; Yan KP; Fenaux P; Losson R; Solary E; Bastie JN; Delva L
    J Clin Invest; 2011 Jun; 121(6):2361-70. PubMed ID: 21537084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-specific 3D genome alteration in acute myeloid leukaemia.
    Xu J; Song F; Lyu H; Kobayashi M; Zhang B; Zhao Z; Hou Y; Wang X; Luan Y; Jia B; Stasiak L; Wong JH; Wang Q; Jin Q; Jin Q; Fu Y; Yang H; Hardison RC; Dovat S; Platanias LC; Diao Y; Yang Y; Yamada T; Viny AD; Levine RL; Claxton D; Broach JR; Zheng H; Yue F
    Nature; 2022 Nov; 611(7935):387-398. PubMed ID: 36289338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.
    Noguera NI; Travaglini S; Scalea S; Catalanotto C; Reale A; Zampieri M; Zaza A; Ricciardi MR; Angelini DF; Tafuri A; Ottone T; Voso MT; Zardo G
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of CEBPδ recovers exhaustion in anti-metastatic immune cells.
    Yin C; Kato M; Tomita T; Han Y; Hiratsuka S
    Sci Rep; 2023 Mar; 13(1):3903. PubMed ID: 36890150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
    Hartl L; Roelofs JJTH; Dijk F; Bijlsma MF; Duitman J; Spek CA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Cancer-Associated Fibroblast-Related Prognostic Model in Breast Cancer via Bulk and Single-Cell RNA Sequencing.
    Hu J; Jiang Y; Wei Q; Li B; Xu S; Wei G; Li P; Chen W; Lv W; Xiao X; Lu Y; Huang X
    Biomed Res Int; 2022; 2022():2955359. PubMed ID: 36510567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-β1/SMAD3 signaling.
    Ren T; Wang J; Tang W; Chen D; Wang S; Zhang X; Yang D
    Clin Exp Med; 2023 Jul; 23(3):777-785. PubMed ID: 35867200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian variable selection for high-dimensional data with an ordinal response: identifying genes associated with prognostic risk group in acute myeloid leukemia.
    Zhang Y; Archer KJ
    BMC Bioinformatics; 2021 Nov; 22(1):539. PubMed ID: 34727888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
    Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.
    Sorrentino VG; Thota S; Gonzalez EA; Rameshwar P; Chang VT; Etchegaray JP
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of EPA on Neonatal Pig Sertoli Cells "
    Arato I; Ceccarelli V; Mancuso F; Bellucci C; Lilli C; Ferolla P; Perruccio K; D'Arpino A; Aglietti MC; Calafiore R; Cameron DF; Calvitti M; Baroni T; Vecchini A; Luca G
    Front Endocrinol (Lausanne); 2021; 12():694796. PubMed ID: 34093450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation.
    Lai HY; Tsai HH; Yen CJ; Hung LY; Yang CC; Ho CH; Liang HY; Chen FW; Li CF; Wang JM
    Front Cell Dev Biol; 2020; 8():596655. PubMed ID: 33681180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.
    Hartl L; Duitman J; Aberson HL; Chen K; Dijk F; Roelofs JJTH; Dings MPG; Hooijer GKJ; Hernanda PY; Pan Q; Busch OR; Besselink MGH; Boerman T; Peppelenbosch MP; Bijlsma MF; Spek CA
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model.
    Lan XO; Wang HX; Qi RQ; Xu YY; Yu YJ; Yang Y; Guo H; Gao XH; Geng L
    Mol Med Rep; 2020 Sep; 22(3):2263-2272. PubMed ID: 32705251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Janus" Role of C/EBPs Family Members in Cancer Progression.
    Tolomeo M; Grimaudo S
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity.
    Goldman SL; Hassan C; Khunte M; Soldatenko A; Jong Y; Afshinnekoo E; Mason CE
    Front Genet; 2019; 10():133. PubMed ID: 30881380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.